Unicycive Therapeutics (UNCY) News
NASDAQ: UNCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.11+0.04 (+0.98%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
UNCY news summary
We found 2 recent headlines mentioning Unicycive Therapeutics (UNCY): 2 in the past week and 2 in the past 30 days, most often from PR Newswire. For price context, UNCY is up 0.98% at $4.11. The most recent story, "UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit", was published by PR Newswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Unicycive Therapeutics headlines
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud LawsuitNEW YORK, Oct. 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29,…PR Newswire
- Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitLOS ANGELES, Oct. 7, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Unicycive Therapeutics, Inc. (UNCY) have opportunity to lead the securities…PR Newswire